Comparison of the Efficacy of Cognitive-Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) in Reducing Depression in Women with Multiple Sclerosis (MS)

Assistant Professor, Department of Psychology, School of Psychology, Shahid Beheshti University, Tehran, Iran

PhD Student, Department of Psychology, School of Psychology, Roudehen Branch, Islamic Azad University, Tehran, Iran


Abstract

Background: The goal of the present study was to compare the efficacy of cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT) in reducing depression in women with multiple sclerosis (MS).

Methods: This was a quasi-experimental research with a pretest-posttest design and control group. Among female patients with MS suffering from depressive symptoms attending the Iran MS Society in 2015, a total of 45 patients were selected as the study sample and randomly divided into 3 groups (CBT, ACT, and Control groups) of 15 individuals. The interventions were provided in 8 sessions, each 45 minutes long. The study data were gathered using the Beck Depression Inventory (BDI) and analyzed using SPSS software.

Results: Both CBT and ACT were effective in reducing depression in patients with MS (P < 0.001). However, CBT was more effective than ACT for this purpose.

Conclusion: According to the study results, both CBT and ACT are effective interventions for reducing depression in patients with MS. Given that CBT was more effective than ACT for this purpose, we suggest that it be used as the preferred treatment for depression in patients with MS.

Keywords


  • Cognitive-behavioral therapy
  • Acceptance and commitment Therapy
  • Multiple sclerosis
  • Depression

Full Text


References


Abramovitz, M. (2004). Family Medical Guide, MS. Trans. Hemmatkhah F. Tehran, Iran: Asr-e Ketab.

Altman, D. G., & Bland, J. M. (2003). Interaction revisited: the difference between two estimates. BMJ., 326(7382), 219. Retrieved from PM:12543843

Arnett, P. A., Higginson, C. I., Voss, W. D., Randolph, J. J., & Grandey, A. A. (2002). Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin.Neuropsychol., 16(3), 341-355. doi:10.1076/clin.16.3.341.13852 [doi]. Retrieved from PM:12607147

Beck, A. T. (1979). Cognitive Therapy of Depression. Guilford clinical psychology and psychotherapy series. New York, NY: Guilford Publications.

Beck, A. T. (2005). The current state of cognitive therapy: a 40-year retrospective. Arch.Gen.Psychiatry., 62(9), 953-959. doi:62/9/953 [pii];10.1001/archpsyc.62.9.953 [doi]. Retrieved from PM:16143727

Beck, J. S. (1995). Cognitive Therapy: Basics and Beyond. New York, NY: Guilford Publications.

Booth, A., Clarke, M., Dooley, G., Ghersi, D., Moher, D., Petticrew, M. et al. (2012). The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev., 1, 2. doi:2046-4053-1-2 [pii];10.1186/2046-4053-1-2 [doi]. Retrieved from PM:22587842

Chwastiak, L. A., & Ehde, D. M. (2007). Psychiatric issues in multiple sclerosis. Psychiatr.Clin.North Am., 30(4), 803-817. doi:S0193-953X(07)00074-3 [pii];10.1016/j.psc.2007.07.003 [doi]. Retrieved from PM:17938046

Cohen, J. (2013). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Erlbaum; 1988.

Cooper, C. L., Hind, D., Parry, G. D., Isaac, C. L., Dimairo, M., O'Cathain, A. et al. (2011). Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. Trials., 12, 259. doi:1745-6215-12-259 [pii];10.1186/1745-6215-12-259 [doi]. Retrieved from PM:22168507

Dehghan, A., & Memarian, R. (2013). Abundance of stress, anxiety and depression in multiple sclerosis patients. Alborz Unversity Medical Journal, 2(2), 82-88.

Dennison, L., & Moss-Morris, R. (2010). Cognitive-behavioral therapy: what benefits can it offer people with multiple sclerosis? Expert.Rev.Neurother., 10(9), 1383-1390. doi:10.1586/ern.10.111 [doi]. Retrieved from PM:20819010

DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Control Clin.Trials., 7(3), 177-188. doi:0197-2456(86)90046-2 [pii]. Retrieved from PM:3802833

Dobson, K. S. (1989). A meta-analysis of the efficacy of cognitive therapy for depression. J Consult.Clin.Psychol., 57(3), 414-419. Retrieved from PM:2738214

Dwan, K., Gamble, C., Kolamunnage-Dona, R., Mohammed, S., Powell, C., & Williamson, P. R. (2010). Assessing the potential for outcome reporting bias in a review: a tutorial. Trials., 11, 52. doi:1745-6215-11-52 [pii];10.1186/1745-6215-11-52 [doi]. Retrieved from PM:20462436

Forman, A. C., & Lincoln, N. B. (2010). Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin.Rehabil., 24(3), 211-221. doi:0269215509343492 [pii];10.1177/0269215509343492 [doi]. Retrieved from PM:20026575

Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ., 327(7414), 557-560. doi:10.1136/bmj.327.7414.557 [doi];327/7414/557 [pii]. Retrieved from PM:12958120

Higgins, J. P. T. , Green S. (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. London, UK: The Cochrane Collaboration.

Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2004). Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol.Assess., 8(9), iii, 1-iii,48. doi:95-01-03 [pii]. Retrieved from PM:14982653

Hollon, S. D., Jarrett, R. B., Nierenberg, A. A., Thase, M. E., Trivedi, M., & Rush, A. J. (2005). Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin.Psychiatry., 66(4), 455-468. Retrieved from PM:15816788

Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology., 33(11), 1444-1452. Retrieved from PM:6685237

Leahy, R. L. (2003). Cognitive therapy techniques: a practitioner's guide. New York, NY: Guilford Press.

Leonavicius, R., & Adomaitiene, V. (2012). Impact of depression on multiple sclerosis patients. Central European Journal of Medicine, 7(5), 685-690.

Lewinsohn, P. M. (1975). The Behavioral Study and Treatment of Depression. In M. Hersen, R. M. Eisler, & P. M. Miller (Eds.), Progress in Behavior Modification Progress in Behavior Modification (1 ed., pp. 19-64). Philadelphia, PA: Elsevier.

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ., 339, b2700. Retrieved from PM:19622552

Lincoln, N. B., Yuill, F., Holmes, J., Drummond, A. E., Constantinescu, C. S., Armstrong, S. et al. (2011). Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial. Mult.Scler., 17(10), 1250-1257. doi:1352458511408753 [pii];10.1177/1352458511408753 [doi]. Retrieved from PM:21613332

Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001). Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult.Clin.Psychol., 69(6), 942-949. Retrieved from PM:11777121

Mokhtari, S. (2004). Investigate the effectiveness of cognitive behavioral therapy on depression in patients with licensed [MSc Thesis]. Isfahan, Iran: University of Isfahan.

Mokhtari, S., Neshat Doost, T., & Molavi, H. (2008). The Effect of Cognitive-Behavior Group Therapy on Depression and Dogmatization of Patients with Multiple Sclerosis (M.S.). Journal of Psychology, 12(3), 242-251.

Moore, P., Hirst, C., Harding, K. E., Clarkson, H., Pickersgill, T. P., & Robertson, N. P. (2012). Multiple sclerosis relapses and depression. J Psychosom.Res, 73(4), 272-276. doi:S0022-3999(12)00209-7 [pii];10.1016/j.jpsychores.2012.08.004 [doi]. Retrieved from PM:22980532

Omrani, S., Mirzaeian, B., Aghabagheri, H., Hassanzadeh, R., & Abedini, M. (2012). Investigating Effectuality of Cognitive-Behavioral Therapy (CBT) as Group Method on the basis of Hope Rate in Patients Suffering from Multiple Sclerosis (M.S). J Mazandaran Univ Med Sci, 22(93), 58-65.

Patten, S. B., & Metz, L. M. (2002). Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis. Int.J Psychiatry.Med, 32(2), 155-165. doi:10.2190/2G2N-WE19-NM47-JNY8 [doi]. Retrieved from PM:12269596

Patten, S. B., Beck, C. A., Williams, J. V., Barbui, C., & Metz, L. M. (2003). Major depression in multiple sclerosis: a population-based perspective. Neurology., 61(11), 1524-1527. Retrieved from PM:14663036

Pittion-Vouyovitch, S., Debouverie, M., Guillemin, F., Vandenberghe, N., Anxionnat, R., & Vespignani, H. (2006). Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci, 243(1-2), 39-45. doi:S0022-510X(05)00438-7 [pii];10.1016/j.jns.2005.11.025 [doi]. Retrieved from PM:16434057

Sanchez Lopez, M. P., Olivares, P. T., Nieto, B. A., Hernandez Perez, M. A., & Barroso, R. J. (2004). [Multiple sclerosis and depression]. Rev.Neurol, 38(6), 524-529. doi:rn2003543 [pii]. Retrieved from PM:15054715

Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA., 273(5), 408-412. Retrieved from PM:7823387

Sharrack, B., & Hughes, R. A. (1999). The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult.Scler., 5(4), 223-233. doi:10.1177/135245859900500406 [doi]. Retrieved from PM:10467380

Thomas, P. W., Thomas, S., Hillier, C., Galvin, K., & Baker, R. (2006). Psychological interventions for multiple sclerosis. Cochrane.Database.Syst Rev.,(1), CD004431. doi:10.1002/14651858.CD004431.pub2 [doi]. Retrieved from PM:16437487

van der Werf, S. P., Evers, A., Jongen, P. J., & Bleijenberg, G. (2003). The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis. Mult.Scler., 9(1), 89-94. doi:10.1191/1352458503ms854oa [doi]. Retrieved from PM:12617274

Voss, W. D., Arnett, P. A., Higginson, C. I., Randolph, J. J., Campos, M. D., & Dyck, D. G. (2002). Contributing factors to depressed mood in Multiple Sclerosis. Arch.Clin.Neuropsychol., 17(2), 103-115. doi:S0887617700000949 [pii]. Retrieved from PM:14589740

Walker, I. D., & Gonzalez, E. W. (2007). Review of intervention studies on depression in persons with multiple sclerosis. Issues Ment.Health Nurs., 28(5), 511-531. doi:779877956 [pii];10.1080/01612840701344480 [doi]. Retrieved from PM:17613150

Wallin, M. T., Wilken, J. A., Turner, A. P., Williams, R. M., & Kane, R. (2006). Depression and multiple sclerosis: Review of a lethal combination. J Rehabil.Res Dev, 43(1), 45-62. Retrieved from PM:16847771

Wineman, N. M., Schwetz, K. M., .Zeller, R., & Cyphert, J. (2003). Longitudinal analysis of illness uncertainty, coping, hopefulness, and mood during participation in a clinical drug trial. J Neurosci Nurs, 35(2), 100-106

Ziemssen, T. (2009). Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci, 277(Suppl 1), S37-S41. doi:S0022-510X(09)70011-5 [pii];10.1016/S0022-510X(09)70011-5 [doi]. Retrieved from PM:19200865




DOI: http://dx.doi.org/10.22122/ijbmc.v5i1.117